Literature DB >> 18506570

Spinal cord atrophy in spinocerebellar ataxia type 3 and 6 : impact on clinical disability.

Carsten Lukas1, Horst K Hahn, Barbara Bellenberg, Kerstin Hellwig, Christoph Globas, Sebastian K Schimrigk, Odo Köster, Ludger Schöls.   

Abstract

OBJECTIVE: To quantify spinal cord atrophy and its impact on clinical disability in spinocerebellar ataxia (SCA) type 3 and 6.
METHODS: Atrophy of the upper spinal cord was assessed by high resolution T1-weighted MRI of patients with SCA3 (n = 14) and SCA6 (n = 10). Furthermore, two groups of age- and sex-matched healthy control subjects (n = 24,) corresponding to the two SCA groups, were studied. Images were post-processed by a semi-automated volumetry method combining a marker based segmentation and an automatic histogram method facilitating highly reliable quantification and morphometry of the upper cervical cord in vivo.
RESULTS: We found a significant reduction of normalized mean crosssectional area of the spinal cord in SCA3 (p < 0.0005), whereas in SCA6 patients normalized mean crosssectional area was in the normal range (p = 0.379). No correlation was found between spinal cord atrophy and disease duration as well as CAG repeat length in both subtypes. In SCA6 a negative dependency between clinical disability, as expressed by the International Cooperative Ataxia Rating Scale as a well established ataxia score, and the mean cross-sectional area was found (p = 0.02). A similar correlation was observed in SCA3 but did not reach statistical significance.
CONCLUSION: Our results quantify for the first time in vivo spinal cord atrophy as a non-cerebellar neurodegenerative process in SCA3. Our results suggest MR volumetry of the upper cervical cord as a marker of functional importance in SCA3 and SCA6.

Entities:  

Mesh:

Year:  2008        PMID: 18506570     DOI: 10.1007/s00415-008-0907-6

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  22 in total

1.  A reliable and efficient method for cerebral ventricular volumetry in pediatric neuroimaging.

Authors:  H K Hahn; W S Millar; O Klinghammer; M S Durkin; P K Tulipano; H-O Peitgen
Journal:  Methods Inf Med       Date:  2004       Impact factor: 2.176

2.  Spinocerebellar ataxia type 6: MRI of three Japanese patients.

Authors:  J I Satoh; H Tokumoto; M Yukitake; M Matsui; Z Matsuyama; H Kawakami; S Nakamura; Y Kuroda
Journal:  Neuroradiology       Date:  1998-04       Impact factor: 2.804

3.  Friedreich's ataxia: MR findings involving the cervical portion of the spinal cord.

Authors:  M Mascalchi; F Salvi; S Piacentini; C Bartolozzi
Journal:  AJR Am J Roentgenol       Date:  1994-07       Impact factor: 3.959

4.  Characteristic magnetic resonance imaging findings in Machado-Joseph disease.

Authors:  Y Murata; S Yamaguchi; H Kawakami; Y Imon; H Maruyama; T Sakai; T Kazuta; T Ohtake; M Nishimura; T Saida; S Chiba; T Oh-i; S Nakamura
Journal:  Arch Neurol       Date:  1998-01

5.  A clinical and pathologic study of a large Japanese family with Machado-Joseph disease tightly linked to the DNA markers on chromosome 14q.

Authors:  Y Takiyama; S Oyanagi; S Kawashima; H Sakamoto; K Saito; M Yoshida; S Tsuji; Y Mizuno; M Nishizawa
Journal:  Neurology       Date:  1994-07       Impact factor: 9.910

6.  Significance of MRI-confirmed atrophy of the cranial spinal cord in Friedreich's ataxia.

Authors:  K Wessel; G Schroth; H C Diener; W Müller-Forell; J Dichgans
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

7.  Magnetic resonance imaging in "typical" and "late onset" Friedreich's disease and early onset cerebellar ataxia with retained tendon reflexes.

Authors:  G De Michele; F Di Salle; A Filla; G D'Alessio; G Ambrosio; L Viscardi; R Scala; G Campanella
Journal:  Ital J Neurol Sci       Date:  1995-06

8.  Characteristic magnetic resonance imaging findings in spinocerebellar ataxia 6.

Authors:  Y Murata; H Kawakami; S Yamaguchi; M Nishimura; T Kohriyama; F Ishizaki; Z Matsuyama; Y Mimori; S Nakamura
Journal:  Arch Neurol       Date:  1998-10

9.  Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular, and neuropathological features.

Authors:  A Dürr; G Stevanin; G Cancel; C Duyckaerts; N Abbas; O Didierjean; H Chneiweiss; A Benomar; O Lyon-Caen; J Julien; M Serdaru; C Penet; Y Agid; A Brice
Journal:  Ann Neurol       Date:  1996-04       Impact factor: 10.422

Review 10.  Biomarkers and surrogate outcomes in neurodegenerative disease: lessons from multiple sclerosis.

Authors:  David H Miller
Journal:  NeuroRx       Date:  2004-04
View more
  12 in total

1.  Benefit of repetitive intrathecal triamcinolone acetonide therapy in predominantly spinal multiple sclerosis: prediction by upper spinal cord atrophy.

Authors:  Carsten Lukas; Barbara Bellenberg; Horst K Hahn; Jan Rexilius; Robert Drescher; Kerstin Hellwig; Odo Köster; Sebastian Schimrigk
Journal:  Ther Adv Neurol Disord       Date:  2009-11       Impact factor: 6.570

2.  Parametric fMRI of paced motor responses uncovers novel whole-brain imaging biomarkers in spinocerebellar ataxia type 3.

Authors:  João Valente Duarte; Ricardo Faustino; Mercês Lobo; Gil Cunha; César Nunes; Carlos Ferreira; Cristina Januário; Miguel Castelo-Branco
Journal:  Hum Brain Mapp       Date:  2016-06-07       Impact factor: 5.038

Review 3.  Dilemma of multiple system atrophy and spinocerebellar ataxias.

Authors:  Ming Li; Qianqian Ma; Xing Zhao; Can Wang; Huijie Wu; Jinyao Li; Wei Yang
Journal:  J Neurol       Date:  2018-04-26       Impact factor: 4.849

Review 4.  Magnetic resonance imaging biomarkers in patients with progressive ataxia: current status and future direction.

Authors:  Stuart Currie; Marios Hadjivassiliou; Ian J Craven; Iain D Wilkinson; Paul D Griffiths; Nigel Hoggard
Journal:  Cerebellum       Date:  2013-04       Impact factor: 3.847

5.  Quantitative assessment of brain stem and cerebellar atrophy in spinocerebellar ataxia types 3 and 6: impact on clinical status.

Authors:  L Eichler; B Bellenberg; H K Hahn; O Köster; L Schöls; C Lukas
Journal:  AJNR Am J Neuroradiol       Date:  2011-03-03       Impact factor: 3.825

6.  Spinal cord damage in Machado-Joseph disease.

Authors:  Camila N Fahl; Lucas Melo T Branco; Felipe P G Bergo; Anelyssa D'Abreu; Iscia Lopes-Cendes; Marcondes C França
Journal:  Cerebellum       Date:  2015-04       Impact factor: 3.847

7.  Spinal Cord Damage in Spinocerebellar Ataxia Type 1.

Authors:  Carlos Roberto Martins; Alberto Rolim Muro Martinez; Thiago Junqueira Ribeiro de Rezende; Lucas Melo Teixeira Branco; José Luiz Pedroso; Orlando G P Barsottini; Iscia Lopes-Cendes; Marcondes C França
Journal:  Cerebellum       Date:  2017-08       Impact factor: 3.847

Review 8.  Cellular and molecular pathways triggering neurodegeneration in the spinocerebellar ataxias.

Authors:  Antoni Matilla-Dueñas; Ivelisse Sánchez; Marc Corral-Juan; Antoni Dávalos; Ramiro Alvarez; Pilar Latorre
Journal:  Cerebellum       Date:  2010-06       Impact factor: 3.847

9.  Spinal cord atrophy correlates with disability in Friedreich's ataxia.

Authors:  Camila F Chevis; Cynthia B da Silva; Anelyssa D'Abreu; Iscia Lopes-Cendes; Fernando Cendes; Felipe P G Bergo; Marcondes C França
Journal:  Cerebellum       Date:  2013-02       Impact factor: 3.847

10.  Social and Cultural Elements Associated with Neurocognitive Dysfunctions in Spinocerebellar Ataxia Type 2 Patients.

Authors:  Roberto Emmanuele Mercadillo; Víctor Galvez; Rosalinda Díaz; Lorena Paredes; Javier Velázquez-Moctezuma; Carlos R Hernandez-Castillo; Juan Fernandez-Ruiz
Journal:  Front Psychiatry       Date:  2015-06-10       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.